| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 3.16% | 6.4% | -49.76% | 25/68 | 2.31% | 羚锐制药 | 6.99% | 行业排名> |
| 2025-12-31 | 6.29% | 239.47% | -23.57% | 29/68 | 2.77% | 羚锐制药 | 22.39% | 行业排名> |
| 2025-09-30 | 8.23% | 201.47% | 39.49% | 20/68 | 4.88% | 达仁堂 | 25.38% | 行业排名> |
| 2025-06-30 | 5.9% | 213.83% | 98.65% | 20/68 | 3.21% | 羚锐制药 | 13.67% | 行业排名> |
| 2025-03-31 | 2.97% | 203.06% | 165.85% | 22/68 | 2.25% | 天目药业 | 9.27% | 行业排名> |
| 2024-12-31 | -4.51% | -285.6% | -265.2% | 55/68 | 3.28% | 天目药业 | 22.26% | 行业排名> |
| 2024-09-30 | 2.73% | -63.21% | 45.21% | 43/68 | 5.46% | 羚锐制药 | 20.44% | 行业排名> |
| 2024-06-30 | 1.88% | -60.67% | 91.84% | 41/68 | 2.54% | 羚锐制药 | 13.25% | 行业排名> |
| 2024-03-31 | 0.98% | -72.93% | -59.67% | 49/68 | 1.97% | 片仔癀 | 7.03% | 行业排名> |
| 2023-12-31 | 2.43% | 120.23% | -67.25% | 50/68 | 2.03% | 片仔癀 | 23.1% | 行业排名> |
| 2023-09-30 | 7.42% | -12.6% | 55.23% | 30/68 | 7.62% | 太极集团 | 22.08% | 行业排名> |
| 2023-06-30 | 4.78% | 10.14% | 32.04% | 33/68 | 5.2% | 太极集团 | 17.13% | 行业排名> |
| 2023-03-31 | 3.62% | 23.13% | 130.14% | 24/68 | 3.31% | 以岭药业 | 10.43% | 行业排名> |
| 2022-12-31 | -12.01% | -258.23% | -241.46% | 61/68 | 6.79% | *ST吉药 | 72.63% | 行业排名> |
| 2022-09-30 | 8.49% | -5.67% | 95.62% | 24/68 | 5.19% | 片仔癀 | 23.54% | 行业排名> |
| 2022-06-30 | 4.34% | -24.26% | 47.62% | 31/68 | 3.33% | 片仔癀 | 19.69% | 行业排名> |
| 2022-03-31 | 2.94% | 0.68% | -61.26% | 24/68 | 2.18% | 片仔癀 | 12.75% | 行业排名> |
| 2021-12-31 | 7.59% | -39.23% | -15.67% | 33/68 | 4.51% | 片仔癀 | 6.88% | 行业排名> |
| 2021-09-30 | 9% | -11.42% | 57.07% | 25/68 | 7.47% | 片仔癀 | 27.39% | 行业排名> |
| 2021-06-30 | 5.73% | 4.56% | 96.23% | 22/68 | 4.6% | 片仔癀 | 23.14% | 行业排名> |
| 2021-03-31 | 2.92% | 32.13% | -76.62% | 24/68 | 2.63% | 片仔癀 | 13.23% | 行业排名> |
| 2020-12-31 | 12.49% | -4.66% | 22.93% | 12/68 | 0.07% | 长药退 | 7.37% | 行业排名> |
| 2020-09-30 | 10.16% | 2.63% | 85.4% | 17/68 | 6.89% | 以岭药业 | 7.15% | 行业排名> |
| 2020-06-30 | 5.48% | 8.51% | 147.96% | 19/68 | 3.83% | 沃华医药 | 22.84% | 行业排名> |
| 2020-03-31 | 2.21% | 8.33% | -83.13% | 28/68 | 2.18% | 沃华医药 | 19.47% | 行业排名> |
| 2019-12-31 | 13.1% | 15.93% | 32.32% | 16/68 | 6.88% | 沃华医药 | 12.7% | 行业排名> |
| 2019-09-30 | 9.9% | 9.03% | 96.04% | 16/68 | 7.39% | 济川药业 | 7.33% | 行业排名> |
| 2019-06-30 | 5.05% | 27.53% | 147.55% | 32/68 | 4.75% | 济川药业 | 27.43% | 行业排名> |
| 2019-03-31 | 2.04% | 30.77% | -81.95% | 42/68 | 2.94% | 济川药业 | 23.05% | 行业排名> |
| 2018-12-31 | 11.3% | -0.62% | 24.45% | 26/68 | 7.89% | 济川药业 | 15.79% | 行业排名> |
| 2018-09-30 | 9.08% | 1.91% | 129.29% | 25/68 | 8.02% | 华润三九 | 10.23% | 行业排名> |
| 2018-06-30 | 3.96% | -23.55% | 153.85% | 39/68 | 5.05% | 济川药业 | 32.79% | 行业排名> |
| 2018-03-31 | 1.56% | -10.86% | -86.28% | 46/68 | 2.78% | 济川药业 | 27.55% | 行业排名> |
| 2017-12-31 | 11.37% | -38.34% | 27.61% | 26/68 | 9.95% | 济川药业 | 17.62% | 行业排名> |
| 2017-09-30 | 8.91% | -39.1% | 72.01% | 27/68 | 8.4% | 济川药业 | 10.07% | 行业排名> |
| 2017-06-30 | 5.18% | -28.55% | 196% | 35/68 | 5.23% | ST葫芦娃 | 46.01% | 行业排名> |
| 2017-03-31 | 1.75% | 2% | -90.51% | 40/68 | 2.66% | 济川药业 | 24.2% | 行业排名> |
| 2016-12-31 | 18.44% | -38.29% | 26.04% | 10/68 | 10.19% | *ST大药 | 15.31% | 行业排名> |
| 2016-09-30 | 14.63% | 2% | 101.79% | 8/68 | 9.47% | 济川药业 | 14.64% | 行业排名> |
| 2016-06-30 | 7.25% | 2% | -75.74% | 21/68 | 5.15% | 济川药业 | 7.64% | 行业排名> |

微信公众号
证券之星APP


